Hearing Loss Biotech Sued By Investor Over 78% Stock Drop
Frequency Therapeutics Inc. and its chief executive hid disastrous clinical trial results that undermined the prospects of its lead hearing loss treatment while dumping shares before the findings became public, an...To view the full article, register now.
Already a subscriber? Click here to view full article